Table 1.

Patient demographics for the intention-to-treat population

	Loteprednol etabonate gel (n = 206)	Vehicle (n = 201)	Overall (n = 407)
Age (years)
Mean (standard deviation)	68.3 (9.66)	69.4 (9.56)	68.9 (9.62)
Median (range)	69.0 (30, 89)	71.0 (43, 88)	70.0 (30, 89)
Race, n (%)
White	151 (73.3%)	149 (74.1%)	300 (73.7%)
Black/African American	22 (10.7%)	21 (10.4%)	43 (10.6%)
American Indian/Alaskan	2 (1.0%)	2 (1.0%)	4 (1.0%)
Asian	28 (13.6%)	25 (12.4%)	53 (13.0%)
Other race	3 (1.5%)	4 (2.0%)	7 (1.7%)
Gender, n (%)
Male	82 (39.8%)	92 (45.8%)	174 (42.8%)
Female	124 (60.2%)	109 (54.2%)	233 (57.2%)
Ethnicity, n (%)
Not Hispanic and not Latino	189 (91.7%)	181 (90.0%)	370 (90.9%)
Hispanic or Latino	17 (8.3%)	20 (10.0%)	37 (9.1%)
Country, n (%)
US	198 (96.1%)	193 (96.0%)	391 (96.1%)
Germany	8 (3.9%)	8 (4.0%)	16 (3.9%)